What is Angioedema?

Angioedema is a condition characterized by sudden, pronounced swelling of the deeper layers of the skin. Unlike common hives (urticaria) which affect the surface layers, angioedema involves the subcutaneous tissues, causing more significant and potentially dangerous swelling. This condition most commonly affects areas with loose connective tissue such as the face (especially the lips and eyelids), hands, feet, genitals, and in some cases, the throat and digestive tract.

There are several types of angioedema, each with distinct causes. Hereditary angioedema (HAE) is a rare genetic disorder caused by C1 esterase inhibitor deficiency. Acquired angioedema can be triggered by allergic reactions to foods, medications, insect stings, or environmental factors. Medication-induced angioedema is commonly associated with ACE inhibitors used to treat high blood pressure. Idiopathic angioedema occurs without an identifiable cause, making it challenging to manage effectively. Understanding the specific type is crucial for determining the most appropriate treatment approach.

Recognizing Angioedema Symptoms

The primary symptom of angioedema is the sudden appearance of swelling beneath the skin. This swelling typically develops over minutes to hours and may persist for up to 72 hours before gradually subsiding. Unlike the itchy welts of urticaria, angioedema swelling is often described as painful, burning, or causing a feeling of tightness.

Common symptoms of angioedema include:

  • Facial swelling - particularly affecting the lips, eyelids, and cheeks
  • Swollen hands, feet, or genitals
  • Difficulty breathing or swallowing when throat tissues are affected
  • Abdominal pain, nausea, and vomiting when intestinal walls swell
  • Hoarse voice due to laryngeal swelling

It's important to note that angioedema affecting the throat (laryngeal edema) constitutes a medical emergency as it can obstruct airways and lead to life-threatening breathing difficulties. Hereditary angioedema often presents with recurrent episodes of swelling and may be accompanied by gastrointestinal symptoms, while allergic angioedema might occur alongside hives and other allergic manifestations.

1. Antihistamine Therapy

Antihistamines represent the first-line treatment for allergic and idiopathic angioedema. These medications work by blocking the action of histamine, a chemical released during allergic reactions that contributes to inflammation and swelling. Both over-the-counter and prescription antihistamines may be used, with second-generation (non-drowsy) options often preferred for daily management.

For acute episodes, higher doses or combinations of antihistamines may be prescribed. Long-term antihistamine therapy can be particularly effective for preventing recurrent idiopathic angioedema episodes. Common antihistamines used include cetirizine, loratadine, and fexofenadine for daily prevention, while diphenhydramine might be used for acute episodes despite its sedating effects. Some patients with chronic angioedema may benefit from scheduled antihistamine dosing rather than as-needed use to maintain consistent symptom control.

2. Corticosteroid Medications

Corticosteroids are powerful anti-inflammatory medications that can effectively reduce swelling in acute angioedema episodes, particularly those with an allergic or inflammatory component. These medications work by suppressing the immune response and decreasing inflammation throughout the body.

Commonly prescribed corticosteroids for angioedema include prednisone, methylprednisolone, and dexamethasone. They may be administered orally, intravenously, or by injection depending on the severity of symptoms. While highly effective for short-term management of acute episodes, long-term corticosteroid use is generally avoided due to potential side effects including weight gain, mood changes, increased blood sugar, and bone density loss. Corticosteroids are typically used alongside antihistamines rather than as monotherapy, providing a complementary approach to managing angioedema symptoms.

3. Epinephrine Auto-Injectors

For severe allergic angioedema episodes, especially those involving throat swelling or occurring as part of anaphylaxis, epinephrine (adrenaline) is the critical emergency treatment. Epinephrine auto-injectors such as EpiPen deliver a measured dose of epinephrine that works rapidly to constrict blood vessels, relax airway muscles, and reduce swelling.

Patients with a history of severe allergic reactions or angioedema affecting the airways are typically prescribed epinephrine auto-injectors to carry at all times. These devices are designed for immediate self-administration into the outer thigh muscle at the first sign of a severe reaction. After using an epinephrine auto-injector, immediate medical attention should still be sought, as the effects are temporary and additional treatment may be necessary. Healthcare providers often recommend having multiple auto-injectors available and ensuring family members and close contacts know how to administer them in an emergency.

4. C1 Esterase Inhibitor Replacement

For hereditary angioedema (HAE) caused by C1 esterase inhibitor deficiency, replacement therapy is a targeted and effective approach. C1 inhibitor concentrates replace the missing or dysfunctional protein responsible for regulating inflammatory pathways that lead to angioedema.

Several C1 inhibitor products are available, including Cinryze and Berinert. These medications can be used both for acute attacks and as routine prophylaxis to prevent episodes in patients with frequent or severe HAE attacks. Administration typically involves intravenous infusion, though newer formulations allow for subcutaneous injection, improving convenience for patients requiring regular treatment. C1 esterase inhibitor replacement therapy has dramatically improved quality of life for HAE patients, reducing both the frequency and severity of potentially dangerous swelling episodes.

5. Bradykinin Receptor Antagonists

Bradykinin receptor antagonists represent an innovative treatment approach specifically developed for hereditary angioedema. These medications target the bradykinin B2 receptor, blocking the effects of excessive bradykinin that causes the vascular leakage and swelling characteristic of HAE attacks.

The most notable medication in this category is icatibant (Firazyr), administered as a subcutaneous injection during acute HAE attacks. Unlike treatments that replace missing proteins, icatibant works directly at the receptor level to prevent bradykinin's effects. The advantage of this approach includes rapid onset of action and the ability to self-administer the medication subcutaneously, allowing patients to treat attacks promptly without requiring intravenous access. This treatment is specifically indicated for HAE and is not typically used for other forms of angioedema.

6. Kallikrein Inhibitors

Kallikrein inhibitors represent another targeted approach for managing hereditary angioedema. These medications work by inhibiting plasma kallikrein, an enzyme involved in the production of bradykinin, thereby reducing the underlying cause of swelling in HAE.

Lanadelumab (Takhzyro) is a monoclonal antibody that inhibits plasma kallikrein, administered as a subcutaneous injection every two to four weeks for HAE prophylaxis. Another option is ecallantide (Kalbitor), used for treating acute HAE attacks. These medications have shown remarkable efficacy in reducing attack frequency and severity in clinical trials. Kallikrein inhibitors represent an important advancement in HAE management, offering long-acting prophylaxis options that significantly improve quality of life for patients with this rare genetic condition by reducing the burden of frequent attacks and emergency treatments.

7. Medication Adjustment and Avoidance

For angioedema caused by medications, particularly ACE inhibitors, the most effective treatment is discontinuation of the triggering drug. ACE inhibitor-induced angioedema can occur at any time during treatment, even after years of use without problems, and typically affects the face, lips, tongue, and upper airway.

When ACE inhibitor-induced angioedema is identified, healthcare providers will immediately discontinue the medication and switch to an alternative hypertension treatment from a different class, such as angiotensin receptor blockers (ARBs), calcium channel blockers, or diuretics. It's important to note that while ACE inhibitors are the most common medication cause, other drugs including NSAIDs, certain antibiotics, and radiographic contrast media can also trigger angioedema in susceptible individuals. Careful documentation of reactions and medical alert identification are essential for preventing future exposures to known triggers.

Conclusion

Managing angioedema effectively requires a personalized approach based on the specific type and underlying cause. While hereditary angioedema benefits from specialized treatments like C1 inhibitor replacement and kallikrein inhibitors, allergic and idiopathic forms may respond well to antihistamines and corticosteroids. For medication-induced angioedema, identifying and avoiding triggers remains paramount. Regardless of the type, patients experiencing angioedema should work closely with healthcare providers to develop both emergency action plans for acute episodes and long-term management strategies. With appropriate treatment, most people with angioedema can achieve good symptom control and maintain their quality of life despite this challenging condition.

Citations

This content was written by AI and reviewed by a human for quality and compliance.